Novacyt S.A. (ALNOV.PA)

EUR 0.48

(-2.66%)

Total Liabilities Summary of Novacyt S.A.

Novacyt S.A.'s latest annual total liabilities in 2023 was 46.57 Million GBP , up 81.32% from previous year.
Novacyt S.A.'s latest quarterly total liabilities in 2023 FY was 46.57 Million GBP , up 81.32% from previous quarter.
Novacyt S.A. reported annual total liabilities of 25.68 Million GBP in 2022, down -38.67% from previous year.
Novacyt S.A. reported annual total liabilities of 41.88 Million GBP in 2021, down -49.88% from previous year.
Novacyt S.A. reported quarterly total liabilities of 28.24 Million GBP for 2023 Q1, up 9.98% from previous quarter.
Novacyt S.A. reported quarterly total liabilities of 24.83 Million GBP for 2023 Q2, down -12.07% from previous quarter.

Annual Total Liabilities Chart of Novacyt S.A. (2023 - 2011)

Historical Annual Total Liabilities of Novacyt S.A. (2023 - 2011)

Year	Total Liabilities	Total Liabilities Growth
2023	46.57 Million GBP	81.32%
2022	25.68 Million GBP	-38.67%
2021	41.88 Million GBP	-49.88%
2020	83.56 Million GBP	493.86%
2019	14.07 Million EUR	26.14%
2018	11.15 Million EUR	37.94%
2017	8.08 Million EUR	-25.14%
2016	10.8 Million EUR	122.45%
2015	4.85 Million EUR	2.56%
2014	4.73 Million EUR	555.79%
2013	722.07 Thousand EUR	-63.13%
2012	1.95 Million EUR	-2.26%
2011	2 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 FY	46.57 Million GBP	81.32%
2023 Q1	28.24 Million GBP	9.98%
2023 Q2	24.83 Million GBP	-12.07%
2023 Q4	46.57 Million GBP	0.0%
2022 Q4	25.68 Million GBP	-12.25%
2022 Q2	33.46 Million GBP	0.0%
2022 FY	25.68 Million GBP	-38.67%
2022 Q3	29.27 Million GBP	-12.52%
2021 Q2	43.62 Million GBP	0.0%
2021 FY	41.88 Million GBP	-49.88%
2021 Q4	41.88 Million GBP	0.0%
2020 Q2	26.69 Million EUR	0.0%
2020 Q4	83.56 Million GBP	0.0%
2020 FY	83.56 Million GBP	493.86%
2019 FY	14.07 Million EUR	26.14%
2019 Q2	14.03 Million EUR	0.0%
2019 Q4	16.47 Million EUR	0.0%
2018 Q4	11.15 Million EUR	0.0%
2018 FY	11.15 Million EUR	37.94%
2018 Q2	10.37 Million EUR	0.0%
2017 Q4	8.08 Million EUR	0.0%
2017 FY	8.08 Million EUR	-25.14%
2017 Q2	10.13 Million EUR	0.0%
2016 Q4	10.8 Million EUR	0.0%
2016 FY	10.8 Million EUR	122.45%
2016 Q2	11.05 Million EUR	0.0%
2015 Q4	4.85 Million EUR	0.0%
2015 Q2	3.61 Million EUR	0.0%
2015 FY	4.85 Million EUR	2.56%
2014 Q2	4.66 Million EUR	0.0%
2014 Q4	4.73 Million EUR	0.0%
2014 FY	4.73 Million EUR	555.79%
2013 FY	722.07 Thousand EUR	-63.13%
2012 FY	1.95 Million EUR	-2.26%
2011 FY	2 Million EUR	0.0%

Peer Total Liabilities Comparison of Novacyt S.A.

Name	Total Liabilities	Total Liabilities Difference
Affluent Medical SA	25.15 Million EUR	-85.174%
Bluelinea Société Anonyme	8.86 Million EUR	-425.376%
Carmat SA	96.83 Million EUR	51.903%
Diagnostic Medical Systems S.A.	37.41 Million EUR	-24.473%
Euromedis Groupe	23.66 Million EUR	-96.784%
Eurobio Scientific Société anonyme	141.15 Million EUR	67.006%
Ikonisys S.A.	5.11 Million EUR	-809.638%
Implanet S.A.	10.81 Million EUR	-330.793%
Median Technologies SA	46.22 Million EUR	-0.746%
SpineGuard SA	5 Million EUR	-830.826%
Theraclion SA	13.01 Million EUR	-257.798%
Euroapi S.A.	684.7 Million EUR	93.198%
Guerbet SA	646.97 Million EUR	92.801%